Actions

Newsfeed Popular Local Discover Follows Blocks Bookmarks Filters Settings PowerUps Help Updates

dailymail.co.uk / Share Newsitem

View, share or embed this newsitem using the details below.

Blood cancer sufferers to be offered pioneering new immunity drugs as 'standard care' on NHS following trial success with patients who did not respond

Watchdogs last week gave the green light for pembrolizumab after studies suggested patients with Hodgkin's lymphoma on it lived longer than those given radiotherapy and chemotherapy.

https://newsreadery.com/go/598caa228adbc4c8c47c25caddf4af6c

Save

Back

Read Full Article